Viewing Study NCT06054932


Ignite Creation Date: 2025-12-24 @ 9:45 PM
Ignite Modification Date: 2025-12-25 @ 7:25 PM
Study NCT ID: NCT06054932
Status: RECRUITING
Last Update Posted: 2023-09-26
First Post: 2023-08-30
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Safety, Tolerability, and Immunogenicity of LK101 Alone in Participants With Incurable Solid Tumors
Sponsor: Beijing Likang Life Science and Tech Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module